Back to recall look-up

Recall archive

94,355 stored notices, from Jun 20, 2012 to Sep 23, 2026.

10 recalls · page 1 of 1

Drugs

Reported Jul 15, 2026

Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

QuVa Pharma, Inc.

Matched: Brand · Product · Product detailsFailed Impurities/Degradation Specifications

FDA (openFDA drug enforcement)

Drugs

Reported Nov 5, 2025

R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

QuVa Pharma, Inc.

Matched: Brand · Product detailsPresence of Particulate Matter

FDA (openFDA drug enforcement)

Drugs

Reported Apr 2, 2025

fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

QuVa Pharma, Inc.

Matched: Brand · Product detailsLack of Assurance of Sterility

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 5, 2022

oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

QuVa Pharma, Inc.

Matched: Brand · Product detailsIncorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).

FDA (openFDA drug enforcement)

Drugs

Reported Jul 1, 2020

R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe,…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

QuVa Pharma, Inc.

Matched: Brand · Product detailsPresence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac

FDA (openFDA drug enforcement)

Drugs

Reported Jun 17, 2020

oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

QuVa Pharma, Inc.

Matched: Brand · Product · Product detailsSubpotent drug - Product did not contain drug.

FDA (openFDA drug enforcement)

Drugs

Reported Dec 11, 2019

fentaNYL 500 mcg/250 mL (2 mcg/mL) Bupivacaine HCl 0.1% 250 mg/250 mL (1 mg/mL) in 0.9% Sodium Chloride 250 mL Bag, Rx…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

QuVa Pharma, Inc.

Matched: Brand · Product detailsPresence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

26 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Dec 19, 2018

Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 mL Bag, Rx only, Compounded by: QuVA Pharma

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

QuVa Pharma, Inc.

Matched: Brand · Product · Product detailsIncorrect excipient: Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride

FDA (openFDA drug enforcement)

Drugs

Reported Sep 26, 2018

Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative Free, Rx only, QuVa Pharma, 519 Route 173,…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

QuVa Pharma, Inc.

Matched: Brand · Product · Product detailsSubpotent Drug: Product may not have the active ingredient present in the bag.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 13, 2016

PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes per case, Rx…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

QuVa Pharma, Inc.

Matched: BrandLabeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10…

FDA (openFDA drug enforcement)

RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up